Details werden geladen...
From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to India - The Economic Times
Indias obesity drug market is set for a new phase as Novo Nordisks oral Wegovy and Eli Lillys oral GLP-1 orforglipron are expected to launch in the first half of 2027. Industry sources said both have been submitted to Indian regulators, potentially expanding demand beyond injectable treatments.
Ähnliche Seiten
Eli Lilly May Launch Oral Obesity Drug Foundayo In India In 2027: CEO David Ricks
https://www.freepressjournal.in/business/eli-lilly-may-launch-oral-obesity-drug-foundayo-in-india-in-2027-ceo-david-ricks
Cheap & Fake Cosmetic, Weight Loss Drug Demand Surges In India | Authorities Take Action | Mint
https://www.livemint.com/videos/cheap-fake-cosmetic-weight-loss-drug-demand-surges-in-india-authorities-take-action-11790941369710.html
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEO - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-biotech-ecosystem-holds-tremendous-promise-eli-lilly-ceo/articleshow/134626584.cmsIndia has biotech talent and know-how, but funding ecosystem lags: Lilly CEO - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-has-biotech-talent-and-know-how-but-funding-ecosystem-lags-lilly-ceo/articleshow/134626945.cmsSuzuki asks India suppliers to move to 6-day, 20-hour operations by Sept 2027, sources say - The Economic Times
https://economictimes.indiatimes.com/industry/auto/auto-news/suzuki-asks-india-suppliers-to-move-to-6-day-20-hour-operations-by-sept-2027-sources-say/articleshow/134632901.cms